These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9715516)

  • 1. TGF alpha is dispensable for skin tumorigenesis in Tg.AC mice.
    Humble MC; Szczesniak CJ; Luetteke NC; Spalding JW; Cannon RE; Hansen LA; Lee DC; Tennant RW
    Toxicol Pathol; 1998; 26(4):562-9. PubMed ID: 9715516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
    Trempus CS; Haseman JK; Tennant RW
    Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
    Shibata MA; Ward JM; Green JE; Merlino G
    Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression.
    Wang XJ; Greenhalgh DA; Eckhardt JN; Rothnagel JA; Roop DR
    Mol Carcinog; 1994 May; 10(1):15-22. PubMed ID: 8185825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic TG.AC mice.
    Hansen LA; Tennant R
    Mol Carcinog; 1994 Mar; 9(3):143-54. PubMed ID: 7908201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
    Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
    Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
    Spalding JW; Momma J; Elwell MR; Tennant RW
    Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse.
    Trempus CS; Bishop WR; Njoroge FG; Doll RJ; Battalora MS; Mahler JF; Haseman JK; Tennant RW
    Mol Carcinog; 2000 Jan; 27(1):24-33. PubMed ID: 10642434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.
    Germolec DR; Spalding J; Yu HS; Chen GS; Simeonova PP; Humble MC; Bruccoleri A; Boorman GA; Foley JF; Yoshida T; Luster MI
    Am J Pathol; 1998 Dec; 153(6):1775-85. PubMed ID: 9846968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse.
    Battalora MS; Spalding JW; Szczesniak CJ; Cape JE; Morris RJ; Trempus CS; Bortner CD; Lee BM; Tennant RW
    Carcinogenesis; 2001 Apr; 22(4):651-9. PubMed ID: 11285202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
    French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
    Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermal carcinogenicity in transgenic mice: relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-O-tetradecanoylphorbol 13-acetate (TPA) and benzene.
    Blanchard KT; Ball DJ; Holden HE; Furst SM; Stoltz JH; Stoll RE
    Toxicol Pathol; 1998; 26(4):541-7. PubMed ID: 9715513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA.
    Thompson KL; Rosenzweig BA; Honchel R; Cannon RE; Blanchard KT; Stoll RE; Sistare FD
    Mol Carcinog; 2001 Dec; 32(4):176-86. PubMed ID: 11746829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice.
    Fuhrman J; Shafer L; Repertinger S; Chan T; Hansen LA
    Toxicol Pathol; 2005; 33(6):623-30. PubMed ID: 16176921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of wound-induced v-Ha-ras transgene expression and papilloma development in transgenic Tg.AC mice.
    Cannon RE; Spalding JW; Trempus CS; Szczesniak CJ; Virgil KM; Humble MC; Tennant RW
    Mol Carcinog; 1997 Sep; 20(1):108-14. PubMed ID: 9328441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of dimethylvinyl chloride increases frequency of forestomach papillomas in Tg.AC mice.
    Cannon RE; Graves S; Spalding JW; Trempus CS; Tennant RW
    Mol Carcinog; 2000 Dec; 29(4):229-35. PubMed ID: 11170261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
    Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
    Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between Ha-ras and fos or transforming growth factor alpha overcomes a paradoxic tumor-inhibitory effect of p53 loss in transgenic mouse epidermis.
    Wang XJ; Greenhalgh DA; Donehower LA; Roop DR
    Mol Carcinog; 2000 Oct; 29(2):67-75. PubMed ID: 11074603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.